Clinical features and treatment outcome
| Case | Age/ sex | Duration of DM | Progression of MM (months) | Weight loss (kg) | Involved nerves | Functional limitations | Pain | Treatment | Follow up (months) | Pain | Functional status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM, diabetes mellitus; F, female; IVIG, intravenous immunoglobulin; IVM, intravenous pulse methylprednisolone 500 mg weekly for 12 weeks; L, left; M, male; MM, mononeuritis multiplex; R, right. | |||||||||||
| 1 | 47/M | 4 years | 18 | 13.6 | R ulnar, L peroneal, L dorsal ulnar cutaneous, L T8 | Brace and cane | Severe | Prednisone | 24 | Resolved within one month | Normal: independent walking |
| 2 | 55/F | 4 years | 18 | 11.4 | L>R peroneal, L ulnar | Wheelchair | Severe | Prednisone, IVIG | 12 | No change | No response: wheelchair |
| 3 | 72/F | 1 year | 16 | 6.8 | L>R peroneal | Walker | Moderate | IVM, chlorambucil | 6 | Improved in two months | Improved: ambulation, cane |
| 4 | 61/F | 3 years | 16 | None | R>L peroneal, L femoral | Brace and cane | Moderate | IVM, chlorambucil | 6 | Improved in two months | Improved: ambulation, brace, and cane |